Twice the power for maximum cellular protection, liver detoxification, and skin luminosity
Monitoring Response Patients or research participants typically notice: Appetite suppression within the first 12 weeks Early satiety and slower gastric emptying by weeks 34 Weight loss trends becoming evident by week 8 Continued improvements in glucose metabolism when paired with semaglutide or tirzepatide Side Effects and Considerations Common side effects include: Nausea Mild gastrointestinal discomfort Constipation Injection site reactions These effects are generally transient and dose-dependent, which is why titration is important
Our BPC-157 research compound is 100% pure, containing no fillers, additives, or extraneous substancesjust high-purity BPC-157 peptide for laboratory use
Leal AD, Qin R, Atherton PJ, et al., Alliance for Clinical Trials in Oncology
Endoscopy 47 , 829854 (2015)